The GOOD trial was a 14-day multicentre randomised double-blind double-dummy non-inferiority trial comparing efficacy between Gaviscon® and omeprazole 20 mg. It recruited 90 general practitioners (GPs ...

Many Part D and Part C plans with drug coverage should cover omeprazole when prescribed by a doctor. In addition, some Part C plans may allow you to purchase it over the counter. Omeprazole (Prilosec) ...

Current guidelines recommend that patients at risk for ulcer disease who require treatment for arthritis receive nonsteroidal antiinflammatory drugs (NSAIDs) that are selective for cyclooxygenase-2 or ...

In 2004, when the original guideline was developed (CG17), doses of proton pump inhibitors (PPIs) were based on the BNF at the time, as in table 1 below. During the update of this guideline (2014), ...

Mumbai, Aug. 8 -- This product is bioequivalent to the reference listed drug (RLD), Prilosec Delayed-Release Tablets, 20 mg (OTC), marketed by AstraZeneca Pharmaceuticals LP under NDA 021229.

The GOOD trial is the first randomised controlled double-blind, double-dummy trial to directly compare efficacy between an alginate and a PPI with heartburn as the clinical primary endpoint. It showed ...